- Home
- THFF vs HUMA Comparison
THFF vs HUMA Comparison
Compare THFF & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- HUMA
- Stock Information
- Founded
- THFF 1984
- HUMA 2004
- Country
- THFF United States
- HUMA United States
- Employees
- THFF N/A
- HUMA N/A
- Industry
- THFF Major Banks
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- HUMA Health Care
- Exchange
- THFF Nasdaq
- HUMA Nasdaq
- Market Cap
- THFF 625.8M
- HUMA 367.6M
- IPO Year
- THFF N/A
- HUMA N/A
- Fundamental
- Price
- THFF $54.19
- HUMA $2.11
- Analyst Decision
- THFF Buy
- HUMA Strong Buy
- Analyst Count
- THFF 2
- HUMA 7
- Target Price
- THFF $56.50
- HUMA $13.00
- AVG Volume (30 Days)
- THFF 54.1K
- HUMA 3.4M
- Earning Date
- THFF 07-22-2025
- HUMA 08-12-2025
- Dividend Yield
- THFF 3.75%
- HUMA N/A
- EPS Growth
- THFF N/A
- HUMA N/A
- EPS
- THFF 4.63
- HUMA N/A
- Revenue
- THFF $215,577,000.00
- HUMA $517,000.00
- Revenue This Year
- THFF $29.97
- HUMA N/A
- Revenue Next Year
- THFF $2.84
- HUMA $896.45
- P/E Ratio
- THFF $11.75
- HUMA N/A
- Revenue Growth
- THFF 9.26
- HUMA N/A
- 52 Week Low
- THFF $35.62
- HUMA $1.15
- 52 Week High
- THFF $54.63
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- THFF 64.58
- HUMA 45.56
- Support Level
- THFF $51.91
- HUMA $2.13
- Resistance Level
- THFF $54.63
- HUMA $2.30
- Average True Range (ATR)
- THFF 1.18
- HUMA 0.16
- MACD
- THFF 0.23
- HUMA -0.06
- Stochastic Oscillator
- THFF 91.04
- HUMA 16.47
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.